Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FB2MH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,398
Award facts
- Contract value 100% obligated
- $17,398.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,398.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on January 8, 2026, with a completion date of January 9, 2026. This contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen). The award represents a small delivery order under AmerisourceBergen's significantly larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
This delivery order falls within the broader scope of the DLA's pharmaceutical supply chain operations, supporting the Defense Health Agency and other federal healthcare systems with critical medications. Zepbound (tirzepatide), a recently approved diabetes and weight management medication, reflects the company's continued role in supplying innovative pharmaceutical products to military treatment facilities and federal health programs. The firm fixed-price structure and competitive award demonstrate AmerisourceBergen's established capability to meet federal procurement requirements for specialized pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FB2MH?
SPE2DR26FB2MH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FB2MH worth?
The government has obligated $17,398 on SPE2DR26FB2MH.
Is contract SPE2DR26FB2MH an order under another contract?
Yes. SPE2DR26FB2MH is a delivery order under SPE2DR25D2102, an indefinite delivery contract.
Was contract SPE2DR26FB2MH competed?
The extent of competition for SPE2DR26FB2MH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award